🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Herbalife Feud With Bill Ackman Continues

Published 04/06/2015, 11:55 AM
Updated 05/14/2017, 06:45 AM
HLF
-

By Sarah Roden

It seems that Herbalife (NYSE:HLF) cannot escape the scrutiny of activist investor Bill Ackman and his hedge fund, Pershing Square Capital Management. Herbalife, the weight loss product distributor, is incorporated in the Cayman Islands and has been accused of being a pyramid scheme in the past. The company has been under investigation by the Federal Trade Commission for the past year.

On March 5, CEO Michael Johnson filed a series of transactions with the SEC. He purchased more than $38 million worth of Herbalife stock, but sold more than $47 million. Overall, he walked away with nearly $9 million. TipRanks has published an article on transactions made by Johnson in the past.

On March 11, Bill Ackman made a presentation highlighting Herbalife’s business practices in China. He contended that Herbalife claims to use an hourly compensation model but really uses a royalty system. Ackman claims that Herbalife’s compensation system in China resembles a pyramid scheme, though Herbalife has denied the allegations.

Now, Herbalife is being investigated by the FTC. Executive Herbalife employees are under investigation, though their identities have not been made public. Herbalife has stated that they are cooperating with the investigation.

Herbalife and Pershing Square have been going back forth accusing each other of fraud. Pershing Square does not mince words, releasing a statement on April 1: “We are pleased that regulators are reviewing Pershing Square’s presentation on Herbalife’s business practices in China. Pershing Square is confident that Herbalife is violating Chinese law prohibiting direct selling and pyramid sales… Herbalife’s SEC filings fail to accurately describe its compensation system in China and, as a result, Herbalife is also in violation of U.S. securities regulations.”

In response to Ackman’s presentation, Herbalife representative Alan Hoffman said, “The fraudulent China research is yet another example of the lengths to which Mr. Ackman will go in his campaign to manipulate Herbalife shares and enrich himself. We remain confident in the strong fundamentals of our business model and committed to helping people and communities improve their nutrition.” In a statement provided to CNBC on April 5, Hoffman added, “We are cooperating with these requests for information, remain confident in the integrity of our business practices, and are hopeful Ackman’s long-term campaign of distortion will be found to be illegal.”

Michael Johnson has a 32% success rate making informative transactions on Herbalife with an average loss of -13.7% average return per transaction.

On average, the top analyst consensus for Herbalife on TipRanks is Strong Buy.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.